Skip to content

Investigations Into Sepsis-associated Acute Kidney Injury

Investigations Into the Mechanisms for Bioenergetic Failure in Sepsis-associated Acute Kidney Injury

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05694624
Enrollment
20
Registered
2023-01-23
Start date
2023-08-14
Completion date
2026-12-31
Last updated
2025-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury

Brief summary

In this study the investigators would like to study systemic and regional disturbances in patients with sepsis-associated acute kidney injury and in healthy controls undergoing laparoscopic abdominal surgery. Specifically study metabolic, hemodynamic and oxygen transport variables.

Detailed description

Acute kidney injury (AKI) in patients with sepsis has a very poor prognosis with up to 60% mortality. The pathobiology remains to be fully understood. Creatine and phosphocreatine, products of arginine metabolism through L-arginine:glycine amidinotransferase (AGAT) and its sister enzyme guanidinoacetate N-methyl-transferase (GAMT), provide an energy-buffering system that is essential for intracellular adenosine triphosphate (ATP) supply. We hypothesized that sepsis associated AKI may be caused by failure of this energy-buffering system. In series of pilot studies, we explored metabolic and bioenergetic patterns in patients and animals with high risk of developing AKI. These data suggest that sepsis associated AKI may be caused by failure of this alternative renal energy source. In the current application we propose a clinical investigation of renal metabolism and renal bioenergetics in patients with high and low risk of developing sepsis associated AKI. The primary objective is to directly investigate renal AGAT activity through the arginyl metabolites homoarginine, guanidino acetate, and creatine. Secondary objectives are to study renal and systemic hemodynamics, renal oxygenation, glomerular filtration rate (GFR), renal tubular function, and mitochondrial respiration.

Interventions

DRUGPara Aminohippurate

Measurements of renal plasma flow and glomerular filtration rate

Sponsors

University Hospital of North Norway
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

sepsis group: * Sepsis diagnosed or suspected * Normal premorbid serum creatinine measured or anticipated (if data are not available) * Normovolemia as indicated by a pulse pressure variation less than 12% Comparator group * Previously healthy individuals scheduled for laparoscopic colon cancer resection * Normal creatinine levels within 3 months before admittance to hospital. * Patients admitted to the intensive care unit with sepsis diagnosed or suspected * Previously healthy patients listed for elective colon cancer surgery

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
HemodynamicsRepeated measures at 10am, 12am, 2pm, 4pm,6pm, and 8pmSystemic and regional hemodynamics

Secondary

MeasureTime frameDescription
Metabolic alterationsRepeated measures at 10am, 12am, 2pm, 4pm,6pm, and 8pmRenal arginine metabolism

Countries

Norway

Contacts

Primary ContactLars M Ytrebo, MD PhD
lars.marius.ytrebo@unn.no+4790788058

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026